Financhill
Sell
28

CRSP Quote, Financials, Valuation and Earnings

Last price:
$40.74
Seasonality move :
16.92%
Day range:
$39.41 - $41.02
52-week range:
$39.41 - $91.10
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.79x
Volume:
3.1M
Avg. volume:
2M
1-year change:
-33.04%
Market cap:
$3.5B
Revenue:
$370M
EPS (TTM):
-$2.80
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $289.6M $543K $913.1M $436K $370M
Revenue Growth (YoY) 9169.85% -99.81% 168054.88% -99.95% 84762.39%
 
Cost of Revenues -- -- $101.2M $110.3M $130.3M
Gross Profit -- -- $811.9M -$109.8M $239.8M
Gross Profit Margin -- -- 88.92% -25186.7% 64.8%
 
R&D Expenses $179.4M $266.9M $340.6M $461.6M $387.3M
Selling, General & Admin $63.5M $88.2M $99.7M $102.5M $76.2M
Other Inc / (Exp) $20.6M $6.4M $6M $22.7M $71.8M
Operating Expenses $242.9M $355M $438.4M $563.3M $462.3M
Operating Income $46.7M -$354.4M $373.5M -$673.2M -$222.5M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $67.3M -$348.1M $379.5M -$650.5M -$150.7M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $448K $809K $1.9M -$325K $2.9M
Net Income to Company $66.9M -$348.9M $377.7M -$650.2M -$153.6M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $66.9M -$348.9M $377.7M -$650.2M -$153.6M
 
Basic EPS (Cont. Ops) $1.23 -$5.29 $4.97 -$8.36 -$1.94
Diluted EPS (Cont. Ops) $1.17 -$5.29 $4.70 -$8.36 -$1.94
Weighted Average Basic Share $54.4M $65.9M $75.9M $77.7M $79.2M
Weighted Average Diluted Share $56.9M $65.9M $80.4M $77.7M $79.2M
 
EBITDA $51.5M -$345.3M $391.5M -$649M -$202.7M
EBIT $46.7M -$354.4M $373.5M -$673.2M -$222.5M
 
Revenue (Reported) $289.6M $543K $913.1M $436K $370M
Operating Income (Reported) $46.7M -$354.4M $373.5M -$673.2M -$222.5M
Operating Income (Adjusted) $46.7M -$354.4M $373.5M -$673.2M -$222.5M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $148K $329K $94K -- --
Revenue Growth (YoY) -99.93% 122.3% -71.43% -- --
 
Cost of Revenues -- $22.5M $38.9M $23.4M $11.2M
Gross Profit -- -$22.1M -$38.8M -$23.4M -$11.2M
Gross Profit Margin -- -6727.96% -41239.36% -- --
 
R&D Expenses $71M $83.5M $116.6M $90.7M $82.2M
Selling, General & Admin $21.5M $23.7M $27M $18.3M $17.4M
Other Inc / (Exp) $160K $1.1M $7.3M $20.7M $25.1M
Operating Expenses $92.5M $106.7M $143.6M $109M $99M
Operating Income -$92.4M -$128.8M -$182.4M -$132.4M -$110.1M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$92.2M -$127.7M -$175.1M -$111.7M -$85.1M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $200K -$595K -$575K $412K $876K
Net Income to Company -$92.4M -$127.2M -$174.5M -$112.2M -$85.9M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$92.4M -$127.2M -$174.5M -$112.2M -$85.9M
 
Basic EPS (Cont. Ops) -$1.32 -$1.67 -$2.24 -$1.41 -$1.01
Diluted EPS (Cont. Ops) -$1.32 -$1.67 -$2.24 -$1.41 -$1.01
Weighted Average Basic Share $70.1M $76.3M $78M $79.4M $85.2M
Weighted Average Diluted Share $70.1M $76.3M $78M $79.4M $85.2M
 
EBITDA -$90.1M -$123.5M -$177.4M -$127.5M -$105.4M
EBIT -$92.4M -$128.8M -$182.4M -$132.4M -$110.1M
 
Revenue (Reported) $148K $329K $94K -- --
Operating Income (Reported) -$92.4M -$128.8M -$182.4M -$132.4M -$110.1M
Operating Income (Adjusted) -$92.4M -$128.8M -$182.4M -$132.4M -$110.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $77.4M $900.9M $12.8M -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- $135.3M $117.1M $130.3M
Gross Profit -- -- -$122.5M $52.9M $69.8M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $233.3M $318.8M $461.2M $395.7M $333.6M
Selling, General & Admin $79.7M $102.8M $105M $80.9M $71.3M
Other Inc / (Exp) $25.4M $4.4M $13.4M $63.3M $95.9M
Operating Expenses $313.1M $420.1M $564.8M $476.6M $402.1M
Operating Income -$235.7M $411.5M -$687.3M -$423.7M -$332.4M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$210.3M $415.8M -$674M -$360.4M -$236.5M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $960K $4M $6.9M -$6.8M $3.1M
Net Income to Company -$211.3M $411.9M -$680.8M -$353.5M -$239.6M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$211.3M $411.9M -$680.8M -$353.5M -$239.6M
 
Basic EPS (Cont. Ops) -$3.24 $5.31 -$8.80 -$4.47 -$2.80
Diluted EPS (Cont. Ops) -$3.26 $4.74 -$8.80 -$4.47 -$2.80
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -$227.6M $425.7M -$662.7M -$402.9M -$313.1M
EBIT -$235.7M $411.5M -$687.3M -$423.7M -$332.4M
 
Revenue (Reported) $77.4M $900.9M $12.8M -- --
Operating Income (Reported) -$235.7M $411.5M -$687.3M -$423.7M -$332.4M
Operating Income (Adjusted) -$235.7M $411.5M -$687.3M -$423.7M -$332.4M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $349K $900.7M $430K $170M --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- $69.4M $103.4M $110.3M $110.3M
Gross Profit -- $831.4M -$103M $59.8M -$110.3M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $184.6M $236.5M $358.1M $292.2M $238.5M
Selling, General & Admin $62.4M $77M $81.3M $59.7M $54.9M
Other Inc / (Exp) $5.8M $3.8M $11.2M $51.8M $75.9M
Operating Expenses $247M $312.2M $438.6M $351.9M $291.7M
Operating Income -$246.7M $519.2M -$541.6M -$292.1M -$402M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$240.9M $523M -$530.4M -$240.3M -$326.1M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $956K $4.1M $9.2M $2.7M $2.9M
Net Income to Company -$241.8M $518.9M -$539.6M -$243M -$328.9M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$241.8M $518.9M -$539.6M -$243M -$328.9M
 
Basic EPS (Cont. Ops) -$3.77 $6.83 -$6.96 -$3.06 -$3.93
Diluted EPS (Cont. Ops) -$3.77 $6.26 -$6.96 -$3.06 -$3.93
Weighted Average Basic Share $192.4M $227.1M $232.6M $237.2M $252M
Weighted Average Diluted Share $192.4M $231.7M $232.6M $237.2M $252M
 
EBITDA -$240.1M $530.9M -$523.3M -$277.2M -$387.6M
EBIT -$246.7M $519.2M -$541.6M -$292.1M -$402M
 
Revenue (Reported) $349K $900.7M $430K $170M --
Operating Income (Reported) -$246.7M $519.2M -$541.6M -$292.1M -$402M
Operating Income (Adjusted) -$246.7M $519.2M -$541.6M -$292.1M -$402M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $943.8M $1.2B $923M $211.9M $389.5M
Short Term Investments -- $521.7M $1.5B $1.6B $1.3B
Accounts Receivable, Net $99K $144K $305K -- $200M
Inventory -- -- -- -- --
Prepaid Expenses $43.7M $26.1M -- -- --
Other Current Assets -- -- $38.1M $37.7M $14.4M
Total Current Assets $987.5M $1.7B $2.4B $1.9B $1.9B
 
Property Plant And Equipment $72.8M $93M $312M $320.6M $305.9M
Long-Term Investments -- -- -- $53.1M $2M
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $6.1M $18.1M $22.2M $16.3M $13.6M
Total Assets $1.1B $1.8B $2.8B $2.2B $2.2B
 
Accounts Payable $5.9M $9.1M $14.8M $27.4M $38.1M
Accrued Expenses $30.2M $53.8M $91M $77.7M $45.3M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $8.5M $11.4M $12.2M $15.8M $15.6M
Other Current Liabilities $11M $7.2M $171K $20K $5.1M
Total Current Liabilities $57.1M $94.3M $119.9M $121.1M $108.8M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $127.3M $163.7M $352.4M $367.6M $346.8M
 
Common Stock $1.8M $2.3M $2.4M $2.4M $2.5M
Other Common Equity Adj $7K -$83K -$5.1M -$15.6M $1.9M
Common Equity $939.4M $1.7B $2.4B $1.9B $1.9B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $939.4M $1.7B $2.4B $1.9B $1.9B
 
Total Liabilities and Equity $1.1B $1.8B $2.8B $2.2B $2.2B
Cash and Short Terms $943.8M $1.7B $2.4B $1.8B $1.7B
Total Debt -- -- -- -- --
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $1B $1B $494.2M $527.8M $225.7M
Short Term Investments $324.6M $1.5B $1.4B $1.2B $1.7B
Accounts Receivable, Net $110K $152K $49K -- --
Inventory -- -- -- -- --
Prepaid Expenses $24.8M $41.4M $36.7M -- --
Other Current Assets -- -- -- $20.8M $8.2M
Total Current Assets $1.4B $2.5B $1.9B $1.8B $1.9B
 
Property Plant And Equipment $76.4M $281M $327.6M $312.3M $284.8M
Long-Term Investments -- -- $77.1M -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $17.5M $21.6M $15.8M $13.9M $27.4M
Total Assets $1.5B $2.8B $2.4B $2.1B $2.3B
 
Accounts Payable $19M $10.2M $32.1M $26.2M $15.6M
Accrued Expenses $35.4M $68.3M $103M $66.4M $47.2M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $10.6M $12.6M $11.3M $15M $16.9M
Other Current Liabilities $12.1M $268K $270K -- $4.8M
Total Current Liabilities $84.1M $96.2M $150.9M $111.2M $89.8M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $141.7M $308.8M $399.4M $359M $316.5M
 
Common Stock $2.2M $2.4M $2.4M $2.5M $2.7M
Other Common Equity Adj -$134K -$770K -$22.3M -$6.8M $10.6M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $1.3B $2.5B $2B $1.7B $1.9B
 
Total Liabilities and Equity $1.5B $2.8B $2.4B $2.1B $2.3B
Cash and Short Terms $1.4B $2.5B $1.9B $1.7B $1.9B
Total Debt -- -- -- -- --
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $66.9M -$348.9M $377.7M -$650.2M -$153.6M
Depreciation & Amoritzation $4.7M $9.2M $18M $24.2M $19.8M
Stock-Based Compensation $44.1M $66M $102.4M $97.9M $81M
Change in Accounts Receivable -$11K -$45K -$161K $305K -$200M
Change in Inventories -- -- -- -- --
Cash From Operations $56.7M -$238.4M $539M -$495.7M -$260.4M
 
Capital Expenditures $6.7M $18.4M $81.7M $37.2M $12M
Cash Acquisitions -- -- -- -- --
Cash From Investing $1.3M -$541.2M -$1B -$258.7M $374.6M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing $431M $1B $250.9M $38.6M $62.7M
 
Beginning Cash (CF) $459.8M $948.8M $1.2B $939.9M $224.1M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $489M $236.6M -$245.5M -$715.8M $176.9M
Ending Cash (CF) $948.8M $1.2B $939.9M $224.1M $401.1M
 
Levered Free Cash Flow $50M -$256.7M $457.3M -$532.9M -$272.3M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$92.4M -$127.2M -$174.5M -$112.2M -$85.9M
Depreciation & Amoritzation $2.3M $5.3M $5M $4.9M $4.7M
Stock-Based Compensation $17.2M $26.2M $24.5M $20M $21.5M
Change in Accounts Receivable -$77K -$2K $17K $70M --
Change in Inventories -- -- -- -- --
Cash From Operations -$75.7M -$81.3M -$105.2M -$39.9M -$106.9M
 
Capital Expenditures $5.5M $37M $6M $3.1M --
Cash Acquisitions -- -- -- -- --
Cash From Investing -$330.3M -$565.2M $87.5M $121.3M -$161.6M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -$7.6M -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing $512.9M $10.2M $15.1M $1.6M $9.6M
 
Beginning Cash (CF) $951.4M $1.7B $513.1M $456.6M $496M
Foreign Exchange Rate Adjustment $33K -$24K -$100K -$48K $75K
Additions / Reductions $106.9M -$636.3M -$2.6M $83M -$258.9M
Ending Cash (CF) $1.1B $1B $510.3M $539.6M $237.2M
 
Levered Free Cash Flow -$81.2M -$118.4M -$111.2M -$43M -$107.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$211.3M $411.9M -$680.8M -$353.5M -$239.6M
Depreciation & Amoritzation $8.1M $14.3M $24.6M $20.8M $19.3M
Stock-Based Compensation $58.9M $95.6M $100.9M $85.4M $83M
Change in Accounts Receivable -$71K -$42K $103K $49K --
Change in Inventories -- -- -- -- --
Cash From Operations -$153.8M $543.8M -$468.5M -$277.6M -$188.8M
 
Capital Expenditures $13.1M $78.8M $40.2M $17.4M --
Cash Acquisitions -- -- -- -- --
Cash From Investing -$329.9M -$1.2B -$91.8M $280.6M -$467.8M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing $908.2M $657.3M $42.4M $26.2M $354M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $424.6M -$29.9M -$517.9M $29.1M -$302.5M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$166.8M $465M -$508.6M -$295.1M -$191.2M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$241.8M $518.9M -$539.6M -$243M -$328.9M
Depreciation & Amoritzation $6.6M $11.7M $18.3M $14.9M $14.4M
Stock-Based Compensation $47.1M $76.6M $75.1M $62.6M $64.6M
Change in Accounts Receivable -$11K -$8K $256K -- $200M
Change in Inventories -- -- -- -- --
Cash From Operations -$157.2M $625M -$382.4M -$164.3M -$92.7M
 
Capital Expenditures $12.1M $72.5M $31M $11.2M --
Cash Acquisitions -- -- -- -- --
Cash From Investing -$336.9M -$1B -$83.1M $456.1M -$386.3M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $0 -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing $603.5M $244.6M $36.1M $23.7M $315.1M
 
Beginning Cash (CF) $2.8B $4B $2.2B $1B $1.6B
Foreign Exchange Rate Adjustment $5K -$14K -$195K $12K $66K
Additions / Reductions $109.4M -$157.1M -$429.4M $315.5M -$163.9M
Ending Cash (CF) $2.9B $3.8B $1.7B $1.4B $1.5B
 
Levered Free Cash Flow -$169.3M $552.5M -$413.4M -$175.5M -$94.4M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock